Samsitaplus Tablet 50/1000 mg

Adult dose

The dosage of this medication is determined based on each patient's current treatment regimen, efficacy, and tolerance, without exceeding the maximum recommended daily doses of sitagliptin 100 mg and metformin 2000 mg per component. 1. For patients currently not treated with metformin: Initially, 50/500 mg of this drug should be taken twice a day, 1 tablet at a time, and it may be increased to 50/1000 mg twice a day, 1 tablet at a time.

This medication may cause serious allergic reactions; therefore, if symptoms such as skin rash, hives, or difficulty breathing occur after ingestion, it should be discontinued immediately and a doctor consulted. This medication carries the risk of inducing inflammation of the pancreas known as acute pancreatitis; if symptoms such as abdominal pain, vomiting, or loss of appetite develop during treatment, medical attention should be sought immediately. One of the ingredients in this medication should not be used in patients with severely impaired renal function, and caution is required in cases of poor kidney function or dehydration. Patients with heart conditions such as heart failure or acute myocardial infarction should avoid this medication. Prior to and following exams that use iodine contrast agents, this medication should be temporarily discontinued, and should only be resumed after confirming that kidney function is normal. It is safer for women who are pregnant, may become pregnant, or are breastfeeding not to take this medication. When prescribing to the elderly, regular monitoring of kidney function and dose adjustment may be necessary. Hypoglycemic symptoms may occur during treatment, so attention should be paid to symptoms of excessively low blood sugar (such as dizziness, cold sweat, headache, etc.). Excessive alcohol consumption should be avoided while taking this medication, as alcohol intake may increase the risk of side effects. This medication may need to be temporarily discontinued around the time of surgery, so it is important to inform medical personnel if surgery is planned. Some patients may experience side effects such as joint pain or skin rash; if unusual symptoms persist, consult a healthcare provider. It is important to have regular blood tests and kidney function tests while taking this medication to check for any abnormalities. In the event of an overdose, seek medical attention immediately for appropriate treatment; some ingredients may be removed through dialysis. The risk of hypoglycemia may increase when this medication is taken with other antidiabetic agents, so consult a healthcare provider regarding interactions with other medications being taken. Adhere to the prescribed dosage and regimen; do not arbitrarily discontinue or change the treatment.

Serious side effects

Hives, angioedema, anaphylaxis, exfoliative skin conditions including Stevens-Johnson syndrome, acute pancreatitis, severe lactic acidosis, acute renal failure, difficulty breathing, unstable angina, severe joint pain accompanied by disability, bullous pemphigoid

Mild side effects

• Diarrhea
• nausea
• vomiting
• abdominal pain
• upper respiratory tract infection
• nasopharyngitis
• headache
• hypoglycemia
• myalgia
• limb pain

This medication should be stored in a tightly sealed container that is well-ventilated and kept at room temperature between 1 to 30 degrees Celsius. Proper storage conditions will help maintain the drug's efficacy for a longer duration.

Appearance

Pink oval film-coated tablets

Package unit

30 tablets/box [(10 tablets/PTP×3)]